Zhang, H.; Zhao, N.; Xie, S.; Li, L.; Zeng, X.; Wang, S.; Yan, L.; Shen, B.; Deng, W.
Targeting LTBP2 Reveals a Novel Anti-Cardiac Remodeling Mechanism of Finerenone Against Doxorubicin-Induced Cardiotoxicity. Biomolecules 2025, 15, 1703.
https://doi.org/10.3390/biom15121703
AMA Style
Zhang H, Zhao N, Xie S, Li L, Zeng X, Wang S, Yan L, Shen B, Deng W.
Targeting LTBP2 Reveals a Novel Anti-Cardiac Remodeling Mechanism of Finerenone Against Doxorubicin-Induced Cardiotoxicity. Biomolecules. 2025; 15(12):1703.
https://doi.org/10.3390/biom15121703
Chicago/Turabian Style
Zhang, Heng, Nan Zhao, Saiyang Xie, Lanlan Li, Xiaofeng Zeng, Shasha Wang, Ling Yan, Bo Shen, and Wei Deng.
2025. "Targeting LTBP2 Reveals a Novel Anti-Cardiac Remodeling Mechanism of Finerenone Against Doxorubicin-Induced Cardiotoxicity" Biomolecules 15, no. 12: 1703.
https://doi.org/10.3390/biom15121703
APA Style
Zhang, H., Zhao, N., Xie, S., Li, L., Zeng, X., Wang, S., Yan, L., Shen, B., & Deng, W.
(2025). Targeting LTBP2 Reveals a Novel Anti-Cardiac Remodeling Mechanism of Finerenone Against Doxorubicin-Induced Cardiotoxicity. Biomolecules, 15(12), 1703.
https://doi.org/10.3390/biom15121703